Komarnicki M, Kaźmierczak M, Hansz J
Department of Hematology, Medical Academy, Poznań, Poland.
Arch Immunol Ther Exp (Warsz). 1994;42(1):31-2.
A preliminary study of six hairy cell leukemia patients treated with one course of 2-chloro-2'-deoxyadenosine (2-CdA) is presented. 2-CdA was administered 0.1 mg/kg/daily by intravenous infusion over 7 days. Two patients achieved CR and four PR.
Zotero 插件